Login / Signup

Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavir.

Yong-Hong WangJuan LiaoDong-Mei ZhangDong-Bo WuYa-Chao TaoMeng-Lan WangEn-Qiang ChenHong Tang
Published in: Journal of medical virology (2019)
TDF + ETV combination therapy for 48 weeks had a higher VR rate than TDF monotherapy in CHB patients with PVR to ETV.
Keyphrases
  • combination therapy
  • antiretroviral therapy
  • acute lymphoblastic leukemia
  • hiv infected
  • hepatitis b virus
  • hiv infected patients
  • virtual reality
  • randomized controlled trial
  • gestational age